PBI3 Comparative Efficacy of Guselkumab and Tildrakizumab in Moderate-to-Severe Plaque Psoriasis: A Matching-Adjusted Indirect Comparison
Abstract
Authors
S. Van Sanden J. Diels A. Schubert J. Barthelmes
S. Van Sanden J. Diels A. Schubert J. Barthelmes
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now